Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases

Publication ,  Conference
Kantor, B; Chiba-Falek, O
Published in: MOLECULAR THERAPY
2022

Duke Scholars

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

2022

Volume

30

Issue

4

Start / End Page

93 / 94

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kantor, B., & Chiba-Falek, O. (2022). Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases. In MOLECULAR THERAPY (Vol. 30, pp. 93–94).
Kantor, Boris, and Ornit Chiba-Falek. “Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases.” In MOLECULAR THERAPY, 30:93–94, 2022.
Kantor B, Chiba-Falek O. Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases. In: MOLECULAR THERAPY. 2022. p. 93–4.
Kantor, Boris, and Ornit Chiba-Falek. “Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 93–94.
Kantor B, Chiba-Falek O. Bimodular CRISPR/Cas-lentiviral Vector for Modeling Diseases. MOLECULAR THERAPY. 2022. p. 93–94.

Published In

MOLECULAR THERAPY

EISSN

1525-0024

ISSN

1525-0016

Publication Date

2022

Volume

30

Issue

4

Start / End Page

93 / 94

Related Subject Headings

  • Biotechnology
  • 3206 Medical biotechnology
  • 3202 Clinical sciences
  • 3105 Genetics
  • 11 Medical and Health Sciences
  • 10 Technology
  • 06 Biological Sciences